Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$98.98 - $115.74 $4.01 Million - $4.68 Million
-40,467 Reduced 90.13%
4,429 $512,000
Q2 2023

Aug 11, 2023

SELL
$96.34 - $112.38 $528,906 - $616,966
-5,490 Reduced 10.9%
44,896 $4.62 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $207,342 - $219,282
1,932 Added 3.99%
50,386 $5.5 Million
Q4 2022

Feb 10, 2023

SELL
$62.39 - $113.8 $481,900 - $878,991
-7,724 Reduced 13.75%
48,454 $5.51 Million
Q3 2022

Nov 10, 2022

SELL
$58.92 - $84.67 $164,151 - $235,890
-2,786 Reduced 4.72%
56,178 $3.48 Million
Q2 2022

Aug 12, 2022

BUY
$79.4 - $116.36 $3.85 Million - $5.64 Million
48,451 Added 460.87%
58,964 $4.7 Million
Q1 2022

May 12, 2022

SELL
$86.42 - $109.81 $51,852 - $65,886
-600 Reduced 5.4%
10,513 $1.11 Million
Q4 2021

Feb 11, 2022

BUY
$98.56 - $119.91 $60,614 - $73,744
615 Added 5.86%
11,113 $1.2 Million
Q3 2021

Nov 05, 2021

BUY
$91.91 - $110.37 $31,800 - $38,188
346 Added 3.41%
10,498 $1.15 Million
Q2 2021

Aug 06, 2021

BUY
$86.24 - $95.92 $4,053 - $4,508
47 Added 0.47%
10,152 $950,000
Q1 2021

May 07, 2021

BUY
$71.83 - $95.48 $562,428 - $747,608
7,830 Added 344.18%
10,105 $930,000
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $1,005 - $1,265
15 Added 0.66%
2,275 $166,000
Q3 2020

Nov 06, 2020

SELL
$55.23 - $79.93 $16,016 - $23,179
-290 Reduced 11.37%
2,260 $175,000
Q2 2020

Aug 07, 2020

SELL
$30.2 - $56.98 $6,160 - $11,623
-204 Reduced 7.41%
2,550 $141,000
Q1 2020

May 08, 2020

BUY
$24.87 - $38.56 $5,222 - $8,097
210 Added 8.25%
2,754 $81,000
Q4 2019

Feb 07, 2020

SELL
$25.43 - $36.67 $8,137 - $11,734
-320 Reduced 11.17%
2,544 $92,000
Q3 2019

Nov 08, 2019

SELL
$23.0 - $27.97 $18,929 - $23,019
-823 Reduced 22.32%
2,864 $77,000
Q2 2019

Aug 09, 2019

BUY
$22.81 - $28.48 $84,100 - $105,005
3,687 New
3,687 $0

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.